COVID-19 Update: All AMP Locations are open, see how we are offering safe in person care and virtual visits. Click here to Learn more about Virtual Care Options.

Due to high call volume, you may experience hold times that are longer than usual.

Non-Discrimination Notice

Successful Xofigo treatment! See our patient's story...

Mr. William Bargabos shown here with his wife completed his six injections of Xofigo on November 13, 2013.  He has enjoyed traveling back and forth from Florida to finish these treatments.

Mr. Bargabos is the first patient in the world treated with Xofigo since it has been made commercially available.

Since the start of treatment, Bill has experienced complete pain relief and has had minimal side effects.  He and his wife will now continue with their normal routine, uninterrupted, wintering in sunny Florida.

Xofigo was approved by the FDA in May of 2013.  The drug is indicated for patients with painful bone metastases from cancer of the prostate. Xofigo has been shown to relieve bony pain and increase survival in these patients.  The A.M.P. Radiation Oncology division is delivering the injections in the office. The drug is given to the patient every month for a total of six injections.

For more information, please contact your Urologist or our Radiation Oncology division!